Emerging evidence suggests that innovative diabetes therapies, particularly GLP-1 RAs and SGLT2 inhibitors, may offer neuroprotective benefits beyond glycemic control, through their favorable effects on metabolic regulation, inflammation, oxidative stress and neuronal survival
Consequently, measurements taken via dual energy X-ray absorptiometry (DEXA) might indicate a relative increase in body fat
This is because of certain hormones released in response to dietary proteins that signal to the brain that you are full, says Whitney Linsenmeyer, PhD, RD, an assistant professor of nutrition and dietetics at Saint Louis University in St
While the medication is absorbed into the bloodstream regardless of the site, many patients report fewer gastrointestinal side effects when injecting into the thigh or arm compared to the stomach
Get Started Disclaimer These therapies are not approved by the FDA to diagnose, treat, cure, or prevent any disease